Saturday, Sep 26, 2020 | Last Update : 06:28 PM IST
186th Day Of Lockdown
Remdesivir
US hospitals turn down remdesivir, limit use to severely ill since July
The slowdown suggests that a shortage of the drug is over and threatens Gilead’s efforts to expand use of remdesivir
12 Sep 2020 1:10 PM
Dr. Reddy’s releases COVID drug Remdesivir under brand name Redyx
"Dr Reddy's Redyx is available in strength of 100 mg vial," it said
09 Sep 2020 12:21 PM
India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial
The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients
13 Aug 2020 11:01 AM
Maharashtra FDA to buy remdesivir from Gujarat firm
State FDA minister Rajendra Shingne said the government plans to publish the price and availability of the drugs online for transparency
26 Jul 2020 3:55 PM
Jubilant Generics gets DCGI nod to manufacture COVID-19 drug Remdesivir
On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions
21 Jul 2020 10:01 AM
Seven held for selling Remdesivir injections at higher cost
The officials said that each vial of the injection was being sold at 30,000 instead of 4,500
20 Jul 2020 12:50 PM
Gilead starts testing inhaled version of remdesivir for COVID-19
Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines
09 Jul 2020 9:10 AM
Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial
The drug will be launched under the brand name Desrem in India and will be available to patients later this month
07 Jul 2020 1:48 PM
Remdesivir gets conditional EU clearance to be used in severe COVID-19 patients
The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US
05 Jul 2020 1:54 PM
Cipla to price remdesivir version for COVID-19 under Rs 5,000
Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.
24 Jun 2020 9:16 AM
Gilead Sciences to start trials of inhaled version of remdesivir
The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19
23 Jun 2020 3:47 PM
Dr Reddy's inks licensing pact with Gilead Sciences for Remdesivir
Gilead Sciences signed similar non-exclusive licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila
14 Jun 2020 9:59 AM
Health ministry okays remdesivir for moderate cases, HCQ for early course of COVID-19
It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma
13 Jun 2020 11:35 PM
India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir
The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak
03 Jun 2020 11:57 AM
Despite FDA warning, Trump says he is taking hydroxychloroquine
The Food and Drug Administration has issued a warning about its use
19 May 2020 10:15 AM
Health groups want India to rescind Gilead drug patents
Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.
15 May 2020 11:46 AM
Gilead ties up with 5 generic drugmakers in India, Pakistan for Covid19 drug supply
The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19
13 May 2020 8:44 AM
US allows use of remdesivir to help virus recovery
No drugs are currently FDA-approved for treating the coronavirus, and remdesivir will still need formal approval
02 May 2020 11:02 AM
US to roll back social distancing guidelines from tomorrow
Trump hopes to hold mass campaign rallies in the coming months, even though experts say there is little hope of having a vaccine by then
30 Apr 2020 10:29 AM
WHO Solidarity trial testing antiviral drug remdesivir, as it could stop coronavirus from replicating
In an observational study, 68 per cent or two out of three patients after treatment with the drug did not require ventilator support
14 Apr 2020 1:51 PM
1 of 1
Columns
On matters of life and death, such as the coronavirus pandemic, it is important that data be in the public domain
Britain arms itself with laws that enable practices that were once the preserve of openly savage savage regimes
The prime minister should have used the debate on farm bills to underscore their virtues
Identifying the border in Arunachal is difficult because the British left large stretches of it without delineation or demarcation